Weighted Average Number of Shares Outstanding, Basic of Replimune Group, Inc. from Q2 2020 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Replimune Group, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and change rate from Q2 2020 to Q3 2025.
  • Replimune Group, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Sep 2025 was 91.9M shares, a 17% increase year-over-year.
  • Replimune Group, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 80.6M shares, a 21% increase from 2023.
  • Replimune Group, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 66.6M shares, a 14.4% increase from 2022.
  • Replimune Group, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 58.2M shares, a 11.5% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

Replimune Group, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 91.9M +13.3M +17% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025
Q2 2025 91.5M +22.3M +32.3% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025
Q1 2025 80.6M +14M +21% 01 Jan 2025 31 Mar 2025 10-K 22 May 2025
Q4 2024 83.5M +16.9M +25.3% 01 Oct 2024 31 Dec 2024 10-Q 12 Feb 2025
Q3 2024 78.6M +12M +18% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025
Q2 2024 69.2M +2.82M +4.25% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025
Q1 2024 66.6M +8.36M +14.4% 01 Jan 2024 31 Mar 2024 10-K 22 May 2025
Q4 2023 66.6M +8.79M +15.2% 01 Oct 2023 31 Dec 2023 10-Q 12 Feb 2025
Q3 2023 66.6M +11.8M +21.6% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024
Q2 2023 66.4M +12.2M +22.4% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024
Q1 2023 58.2M +6M +11.5% 01 Jan 2023 31 Mar 2023 10-K 16 May 2024
Q4 2022 57.9M +5.54M +10.6% 01 Oct 2022 31 Dec 2022 10-Q 08 Feb 2024
Q3 2022 54.8M +2.69M +5.16% 01 Jul 2022 30 Sep 2022 10-Q 07 Nov 2023
Q2 2022 54.2M +2.3M +4.43% 01 Apr 2022 30 Jun 2022 10-Q 03 Aug 2023
Q1 2022 52.2M +5.96M +12.9% 01 Jan 2022 31 Mar 2022 10-K 18 May 2023
Q4 2021 52.3M +2.94M +5.95% 01 Oct 2021 31 Dec 2021 10-Q 09 Feb 2023
Q3 2021 52.1M +8.07M +18.3% 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022
Q2 2021 51.9M +12M +30.2% 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022
Q1 2021 46.2M 01 Jan 2021 31 Mar 2021 10-K 19 May 2022
Q4 2020 49.4M 01 Oct 2020 31 Dec 2020 10-Q 03 Feb 2022
Q3 2020 44M 01 Jul 2020 30 Sep 2020 10-Q 04 Nov 2021
Q2 2020 39.9M 01 Apr 2020 30 Jun 2020 10-Q 06 Aug 2021

Replimune Group, Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 80.6M +14M +21% 01 Apr 2024 31 Mar 2025 10-K 22 May 2025
2023 66.6M +8.36M +14.4% 01 Apr 2023 31 Mar 2024 10-K 22 May 2025
2022 58.2M +6M +11.5% 01 Apr 2022 31 Mar 2023 10-K 16 May 2024
2021 52.2M +5.96M +12.9% 01 Apr 2021 31 Mar 2022 10-K 18 May 2023
2020 46.2M 01 Apr 2020 31 Mar 2021 10-K 19 May 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.